ADIPOQ and type 2 diabetes mellitus: High circulating adiponectin is strongly associated with reduced cardiovascular risk and low adipose tissue adiponectin transcriptional expression is associated with hypoadiponectinemia and could influence the insulin resistance and cardiovascular disease in obesity and type 2 diabetes (7).